What is the diagnosis for a patient with intestinal hypermotility presenting with frequent cramping abdominal pain, urgency, watery stools, and rapid bowel movements, and what diagnostic tests should be performed?

Diagnosis and Testing for Intestinal Hypermotility

The most likely diagnosis for a patient presenting with frequent cramping abdominal pain, urgency, watery stools, and rapid bowel movements is irritable bowel syndrome with diarrhea (IBS-D), which is diagnosed using positive symptom-based criteria (Rome IV) after excluding organic disease through targeted screening tests. 1

Diagnostic Approach

Initial Symptom-Based Diagnosis

The diagnosis begins by identifying positive symptoms consistent with IBS-D rather than relying solely on exclusion 1:

• Abdominal pain that is relieved with defecation and/or associated with a change in stool frequency or form for at least 12 weeks (not necessarily consecutive) in the preceding 12 months 1
• Abnormal stool frequency (greater than 3 bowel movements per day) with loose/watery stool form 1
• Urgency and feeling of incomplete evacuation 1
• Absence of alarm features such as fever, unintentional weight loss, blood in stools, nocturnal diarrhea, or recent onset in patients over age 45 1, 2

Mandatory Screening Tests to Exclude Organic Disease

Before confirming IBS-D, the following tests must be performed 1, 2:

• Complete blood count to screen for anemia (which would suggest organic disease) 1, 2
• C-reactive protein or erythrocyte sedimentation rate to identify inflammatory processes 1, 2
• Comprehensive metabolic panel including albumin, electrolytes, and liver function tests 2
• Anti-tissue transglutaminase IgA with total IgA (mandatory for celiac disease screening) 2
• Fecal calprotectin to exclude colonic inflammation; values >50-60 mg/g suggest inflammatory bowel disease and require colonoscopy 2
• Stool Hemoccult for occult blood 1
• Stool for ova and parasites if clinically indicated by geographic area or travel history 1

Age-Stratified Endoscopic Evaluation

Patients ≥50 years require colonoscopy due to higher risk of colon cancer 1. Patients ≥45 years with new-onset symptoms should undergo full colonoscopy with biopsies from right and left colon (not rectum) even if mucosa appears normal, to exclude microscopic colitis 2.

Patients <40 years without alarm features and normal fecal calprotectin can avoid immediate colonoscopy 2.

Specialized Motility Testing (Second-Line)

If symptoms persist despite first-line treatment or are atypical, specialized motility testing may be indicated 1, 3, 4:

Colonic Transit Studies

• Whole gut transit test with radiopaque markers (Sitz markers) to confirm rapid colonic transit 1, 3, 4
• Wireless motility capsule that transmits pH, temperature, and pressure data as it transits the GI tract 1, 3, 4

Colonic Manometry

• Antroduodenal and colonic manometry to measure contractile patterns and identify high-amplitude propagating contractions (HAPCs) that correlate with abdominal pain and rapid transit 5, 6, 3, 4
• Research shows IBS-D patients have significantly increased HAPCs that parallel shortened colonic transit time and coincide with >90% of abdominal pain episodes 5

Additional Motility Tests

• Anorectal manometry and balloon expulsion test if pelvic floor dysfunction is suspected 1
• Breath testing for bacterial overgrowth or lactose intolerance 1, 3, 4

Evaluation for Treatable Causes After Negative Initial Workup

Bile Acid Diarrhea

• SeHCAT testing or serum 7α-hydroxy-4-cholesten-3-one to diagnose bile acid diarrhea, which affects approximately 45% of patients with functional-appearing chronic diarrhea 2
• Empirical cholestyramine trials without objective testing are not recommended 2

Microscopic Colitis

• Requires colonoscopy with biopsies from right and left colon because endoscopic appearance is typically normal 2
• Accounts for approximately 10% of chronic diarrhea cases and 33.4% of IBS-type symptoms 1, 2

Small Intestinal Bacterial Overgrowth

• An empirical antibiotic trial is advised rather than routine breath testing 2

Common Pitfalls to Avoid

• Do not diagnose IBS-D based on Rome criteria alone without completing basic blood and stool screening first, as Rome criteria have only 52-74% specificity 2
• Do not miss microscopic colitis by failing to perform colonoscopy with biopsies in appropriate patients 1, 2
• Do not overlook bile acid diarrhea by skipping objective testing 2
• Do not attribute symptoms to IBS-D in patients ≥45 years without colonoscopy to exclude colorectal cancer 1, 2
• Do not forget celiac serology as diarrhea occurs in 43-85% of newly diagnosed celiac disease patients 2

Clinical Context

Research demonstrates that IBS-D patients exhibit specific colonic dysmotility characterized by increased frequency and amplitude of HAPCs that directly correlate with abdominal pain and rapid transit 5, 6. These powerful contractions are mediated through the enteric nervous system and represent one mechanism of symptom generation 5. However, specialized motility testing is reserved for patients with refractory symptoms who fail first-line therapies 1, 7.